[PDF][PDF] 2019 冠状病毒病(COVID-19) 诊疗浙江经验
徐凯进， 蔡洪流， 沈毅弘， 倪勤， 陈瑜， 胡少华… - 浙江大学学报(医学 …, 2020 - f.cqvip.com
当前2019 冠状病毒病(COVID-19) 疫情仍处于胶着状态, 浙江大学医学院附属第一医院是国家
感染性疾病临床医学中心, 是浙江省COVID-19 救治中心, 战斗在疫情一线的专家集智攻关 …
感染性疾病临床医学中心, 是浙江省COVID-19 救治中心, 战斗在疫情一线的专家集智攻关 …
Management of COVID-19: the Zhejiang experience
K Xu, H Cai, Y Shen, Q Ni, Y Chen, S Hu… - Zhejiang da xue xue …, 2020 - europepmc.org
The current epidemic situation of coronavirus disease 2019 (COVID-19) still remained
severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated …
severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated …
[HTML][HTML] Translation: management of Coronavirus disease 2019 (COVID-19): experience in Zhejiang Province, China
K Xu, H Cai, Y Shen, Q Ni, Y Chen, S Hu… - Infectious Microbes & …, 2020 - journals.lww.com
The current epidemic situation of coronavirus disease 2019 (COVID-19) still remains severe.
As the National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital …
As the National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital …
新型冠状病毒SARS-CoV-2: 高致病性及其防治
刘力 - 基础医学与临床, 2020 - journal11.magtechjournal.com
冠状病毒曾被认为是一类在人群中不致病的或仅引起轻微自愈性疾病的病原体. 但是,
在人类在进入21 世纪的前20 年中, 却经历了2002—2003 年的SARS-CoV, 2012 年的MERS …
在人类在进入21 世纪的前20 年中, 却经历了2002—2003 年的SARS-CoV, 2012 年的MERS …
Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing, China
L Liu, JY Gao, W Hu, X Zhang, L Guo, C Liu, Y Tang… - MedRxiv, 2020 - medrxiv.org
Abstract Background Since December 2019, Severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2)-infected disease (Coronavirus Disease 2019, COVID-19) …
coronavirus 2 (SARS-CoV-2)-infected disease (Coronavirus Disease 2019, COVID-19) …
基于“One Health” 理念的新型冠状病毒肺炎防控策略
李志慧， 李芊璘， 王子晨， 陆家海 - 暨南大学学报: 自然科学与医学版, 2020 - cqvip.com
目的: One Health (同一健康) 指多学科, 多部门, 多地域共同协作, 努力使人类, 动物,
环境三者成为一个健康整体的理念. 在新发传染病暴发时是一种有效的疫情防控管理模式 …
环境三者成为一个健康整体的理念. 在新发传染病暴发时是一种有效的疫情防控管理模式 …
危重型新型冠状病毒肺炎治疗的认识
曹娟， 许红阳， 叶正龙 - 中国临床研究, 2020 - cqvip.com
2019 年12 月国内出现的新型冠状病毒(2019-nCoV) 引起的肺炎, 因其传播迅速引起全世界的
重视, 目前抗新冠病毒尚无特效药, 所以对于患者的救治带来极大的挑战. 为了提高危重型新型 …
重视, 目前抗新冠病毒尚无特效药, 所以对于患者的救治带来极大的挑战. 为了提高危重型新型 …
Combined interventions for severe novel coronavirus disease (COVID-19): experience from 350 patients
T Guo, Q Shen, Z Zhou, J Li, W Guo, W He… - Infection and drug …, 2020 - Taylor & Francis
Purpose To summarize the clinical features and effective therapy of severe COVID-19
patients. Patients and Methods In this retrospective, multicenter study, the medical records of …
patients. Patients and Methods In this retrospective, multicenter study, the medical records of …
Clinical characteristics of refractory coronavirus disease 2019 in Wuhan, China
P Mo, Y Xing, Y Xiao, L Deng, Q Zhao… - Clinical infectious …, 2021 - academic.oup.com
Abstract Background Since December 2019, coronavirus disease 2019 (COVID-19), caused
by severe adult respiratory syndrome coronavirus 2, occurred in Wuhan, and rapidly spread …
by severe adult respiratory syndrome coronavirus 2, occurred in Wuhan, and rapidly spread …
Accumulated clinical experiences from successful treatment of 1377 severe and critically Ill COVID-19 cases
Y Gao, H Qiu, S Zhou, Z Wang, J Zhang, Z Zhang… - Current Medical …, 2020 - Springer
Summary In late December 2019, COVID-19 was firstly recognized in Wuhan, China and
spread rapidly to all of the provinces of China. The West Campus of Wuhan Union Hospital …
spread rapidly to all of the provinces of China. The West Campus of Wuhan Union Hospital …